Companies:
49,941
Total Market Cap:
142452895585663.40
Gentian Diagnostics ASA
OSL-GENT
Healthcare
Medical Devices
Global Rank
#26313
Country Rank
#163
Market Cap
82.07 M
Price
5.3
Change (%)
0.37%
Volume
2,591
Gentian Diagnostics ASA's latest marketcap:
82.07 M
As of 07/26/2025, Gentian Diagnostics ASA's market capitalization has reached $82.07 M. According to our data, Gentian Diagnostics ASA is the 26313th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 82.07 M |
| Revenue (ttm) | 16.1 M |
| Net Income (ttm) | 4.16 M |
| Shares Out | 15.42 M |
| EPS (ttm) | 0.26 |
| Forward PE | 33.50 |
| Ex-Dividend Date | 05/07/2025 |
| Earnings Date | 07/10/2025 |
Market Cap Chart
Data Updated: 07/26/2025
Gentian Diagnostics ASA's yearly market capitalization.
Gentian Diagnostics ASA has seen its market value grow from kr590.37 M to kr832.81 M since 2016, representing a total increase of 41.06% and an annual compound growth rate (CAGR) of 4.10%.
| Date | Market Cap(kr) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/26/2025 | kr832.81 M | $82.07 M | 41.33% | 26313 |
| 12/30/2024 | kr604.56 M | $53.08 M | -5.54% | 27589 |
| 12/29/2023 | kr640.03 M | $62.84 M | 1.22% | 26245 |
| 12/30/2022 | kr632.32 M | $64.43 M | -43.06% | 25160 |
| 12/30/2021 | kr1.11 B | $125.76 M | 32.2% | 21628 |
| 12/30/2020 | kr839.95 M | $97.88 M | -12.61% | 20737 |
| 12/30/2019 | kr961.13 M | $109.47 M | 15.61% | 17651 |
| 12/28/2018 | kr831.38 M | $96.17 M | 44.88% | 17469 |
| 12/29/2017 | kr573.85 M | $69.92 M | -2.8% | 19864 |
| 12/30/2016 | kr590.37 M | $68.3 M | 17789 |
Company Profile
Gentian Diagnostics ASA was founded in 2001 in Norway.
on the Oslo Børs.
With 63 employees, it focuses on Healthcare and aims to drive innovation in Medical Devices.
Frequently Asked Questions
-
What is Gentian Diagnostics ASA's (OSL-GENT) current market cap?As of 07/26/2025, Gentian Diagnostics ASA (including the parent company, if applicable) has an estimated market capitalization of $82.07 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Gentian Diagnostics ASA (OSL-GENT) rank globally by market cap?Gentian Diagnostics ASA global market capitalization ranking is approximately 26313 as of 07/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.